Harvard Bioscience Schedules Fourth Quarter 2017 Conference Call for March 1 at 4:30 PM ET
February 22 2018 - 4:45PM
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer,
manufacturer and marketer of a broad range of solutions to advance
life science, will announce results for its fourth quarter 2017
after market trading hours on Thursday, March 1, 2018. A conference
call to discuss the company's fourth quarter 2017 financial results
and its operations is scheduled for that same date at 4:30 PM ET.
On that call, management may respond to questions from the audience
and provide information on any of a number of topics related to the
business, including operations, plans and outlook.
Participating in the call will be Jeffrey A. Duchemin, President
and Chief Executive Officer; and Robert Gagnon, Chief Financial
Officer of Harvard Bioscience. Investors can access the live
conference call by dialing the following phone numbers: toll-free
1-888-771-4371, or international: 1-847-585-4405, and referencing
the conference ID# 46530979.
The conference will be simultaneously webcast and can be
accessed through the Harvard Bioscience website. To listen to the
webcast, log on to the webcast at:
http://investor.harvardbioscience.com/
and click on the Earnings Call icon. Financial information
presented on the call, including the earnings release, will also be
available on the investor relations section of the website.
If you are unable to listen to the live conference call, the
webcast will be available on the Company's website through March 8,
2018.
To add this meeting to your calendar visit:
http://investor.harvardbioscience.com/ and click “remind
me”.
About Harvard Bioscience
Harvard Bioscience is a global developer, manufacturer and
marketer of a broad range of solutions to advance life science. Our
products are sold to thousands of researchers in over 100 countries
through our global sales organization, websites, catalogs, and
through distributors including Thermo Fisher Scientific Inc., VWR,
and other specialized distributors. We have sales and manufacturing
operations in the United States, the United Kingdom, Germany,
Sweden, Spain, France, Canada and China. For more information,
please visit our website at www.harvardbioscience.com.
CONTACTS:
Corey Manchester
Director, Finance and Investor Relations
Tel: 508 893 8999
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024